IRWD
Price
$3.19
Change
+$0.08 (+2.57%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
507.56M
85 days until earnings call
Intraday BUY SELL Signals
PRGO
Price
$12.96
Change
-$0.42 (-3.14%)
Updated
Nov 19, 01:57 PM (EDT)
Capitalization
1.84B
99 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IRWD vs PRGO

Header iconIRWD vs PRGO Comparison
Open Charts IRWD vs PRGOBanner chart's image
Ironwood Pharmaceuticals
Price$3.19
Change+$0.08 (+2.57%)
Volume$23.44K
Capitalization507.56M
Perrigo
Price$12.96
Change-$0.42 (-3.14%)
Volume$914
Capitalization1.84B
IRWD vs PRGO Comparison Chart in %
IRWD
Daily Signal:
Gain/Loss:
PRGO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IRWD vs. PRGO commentary
Nov 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRWD is a Hold and PRGO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 19, 2025
Stock price -- (IRWD: $3.12 vs. PRGO: $13.39)
Brand notoriety: IRWD and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: IRWD: 123% vs. PRGO: 190%
Market capitalization -- IRWD: $507.56M vs. PRGO: $1.84B
IRWD [@Pharmaceuticals: Generic] is valued at $507.56M. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $1.84B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRWD’s FA Score shows that 0 FA rating(s) are green whilePRGO’s FA Score has 2 green FA rating(s).

  • IRWD’s FA Score: 0 green, 5 red.
  • PRGO’s FA Score: 2 green, 3 red.
According to our system of comparison, PRGO is a better buy in the long-term than IRWD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRWD’s TA Score shows that 5 TA indicator(s) are bullish while PRGO’s TA Score has 4 bullish TA indicator(s).

  • IRWD’s TA Score: 5 bullish, 4 bearish.
  • PRGO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IRWD is a better buy in the short-term than PRGO.

Price Growth

IRWD (@Pharmaceuticals: Generic) experienced а +7.96% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was -6.36% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.77%. For the same industry, the average monthly price growth was -6.55%, and the average quarterly price growth was +28.28%.

Reported Earning Dates

IRWD is expected to report earnings on Feb 12, 2026.

PRGO is expected to report earnings on Feb 26, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.77% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRGO($1.84B) has a higher market cap than IRWD($508M). PRGO has higher P/E ratio than IRWD: PRGO (2818.00) vs IRWD (17.39). IRWD YTD gains are higher at: -29.571 vs. PRGO (-46.162). PRGO has higher annual earnings (EBITDA): 612M vs. IRWD (79.6M). PRGO has more cash in the bank: 454M vs. IRWD (92.9M). IRWD has less debt than PRGO: IRWD (599M) vs PRGO (3.65B). PRGO has higher revenues than IRWD: PRGO (4.33B) vs IRWD (309M).
IRWDPRGOIRWD / PRGO
Capitalization508M1.84B28%
EBITDA79.6M612M13%
Gain YTD-29.571-46.16264%
P/E Ratio17.392818.001%
Revenue309M4.33B7%
Total Cash92.9M454M20%
Total Debt599M3.65B16%
FUNDAMENTALS RATINGS
IRWD vs PRGO: Fundamental Ratings
IRWD
PRGO
OUTLOOK RATING
1..100
2351
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10088
PRICE GROWTH RATING
1..100
3494
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (33) in the Pharmaceuticals Other industry is in the same range as IRWD (59). This means that PRGO’s stock grew similarly to IRWD’s over the last 12 months.

PRGO's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as IRWD (100). This means that PRGO’s stock grew similarly to IRWD’s over the last 12 months.

PRGO's SMR Rating (88) in the Pharmaceuticals Other industry is in the same range as IRWD (100). This means that PRGO’s stock grew similarly to IRWD’s over the last 12 months.

IRWD's Price Growth Rating (34) in the Pharmaceuticals Other industry is somewhat better than the same rating for PRGO (94). This means that IRWD’s stock grew somewhat faster than PRGO’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is significantly better than the same rating for IRWD (100). This means that PRGO’s stock grew significantly faster than IRWD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IRWDPRGO
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
55%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
67%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 7 days ago
66%
Bullish Trend 30 days ago
60%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
66%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
48%
View a ticker or compare two or three
Interact to see
Advertisement
IRWD
Daily Signal:
Gain/Loss:
PRGO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EACPX62.66N/A
N/A
Eaton Vance Tax-Managed Multi-Cap Gr A
SLPIX117.37N/A
N/A
ProFunds Small Cap Inv
ETCHX42.01N/A
N/A
Eventide Healthcare & Life Sciences C
PMYZX47.29-0.31
-0.65%
Putnam Core Equity Fund R
VNSAX23.94-0.25
-1.03%
Natixis Vaughan Nelson Select A

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with ZTS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then ZTS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
-1.25%
ZTS - PRGO
35%
Loosely correlated
-0.56%
ALKS - PRGO
33%
Poorly correlated
-0.34%
EOLS - PRGO
31%
Poorly correlated
+1.44%
SUPN - PRGO
31%
Poorly correlated
-0.42%
ORGO - PRGO
30%
Poorly correlated
-7.93%
More